Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

382 Press Releases
DateTitleCompany
08 May 13 EISAI FILES FOR EARLIER USE OF HALAVEN® (ERIBULIN) FOR THE TREATMENT OF METASTATIC BREAST CANCER Eisai,
Published by
Tonic Life Communications
07 May 13 Ascribe launch Clinical Engagement Networking Group at opening of new Innovation Suite Ascribe
07 May 13 CPhI China 2013 increases customer content services and expands thanks to a double digit pharma industry growth rate and a burgeoning generics market CPhI,
Published by
De Facto Communications
07 May 13 Recipharm and Synthonics join forces to promote novel drug delivery technology Synthonics,
Published by
Defacto
07 May 13 Aesica partners with the University of Nottingham to develop novel amide chemical synthesis technique Aesica,
Published by
Defacto
07 May 13 CLINTEC INTERNATIONAL AND EDINBURGH NAPIER UNIVERSITY ANNOUNCE LAUNCH OF MASTERS CLINTEC INTERNATIONAL ,
Published by
Defacto
02 May 13 Dr. Nilayini, Dr. Shuba Dharmana, Dr.Uday Sidhu,Dr.Tripti Rathore, Dr.Rashmi Lohiya For Skincare Award pharmaleaders,
Published by
Pharmaleaders
01 May 13 Winner of Kelly Services 2012 Global Supplier Excellence Award CK Associates,
Published by
PharmiWeb.com
01 May 13 Prasco announces agreement with WellSpring for the Authorized Generic of DIBENZYLINE® PRASCO LABORATORIES,
Published by
PR Newswire
01 May 13 Discovery Labs Announces Recent AFECTAIR® Publications DISCOVERY LABORATORIES INC,
Published by
PR Newswire
01 May 13 Oxford BioMedica Announces Lentiviral Vector Development and Manufacturing Collaboration Oxford BioMedica,
Published by
PharmiWeb.com
01 May 13 Martindale Pharma® launches Tapclob®, the first licensed oral liquid suspension of clobazam Martindale,
Published by
PharmiWeb.com
01 May 13 Vertex Announces New Data that Showed High Viral Cure Rates with a Total of 12 and 24 Weeks of Telaprevir Combination Treatment Among People with Genotype 1 Hepatitis C Who Have the IL28B CC Genotype Vertex
01 May 13 Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams Lilly
01 May 13 Personalised radiotherapy treatment set to benefit from CERN software Cancer Research UK
30 Apr 13 Malvinder Singh , Dr. K. Ravindranath, Rajiv Bajaj, Nirmal Jain & Joseph Massey are in Race for Business Leader of The Year 2013 pharmaleaders,
Published by
Pharmaleaders
29 Apr 13 Almac Discovery announces licensing of ALM201 to Shin Poong for development and marketing in South Korea Almac Discovery ,
Published by
Defacto
26 Apr 13 Pharma Consulting Group announces acquisition of CSL Recruitment and Consulting Limited. Pharma Consulting Group,
Published by
PharmiWeb.com
26 Apr 13 NICE gives seal of approval to balloon kyphoplasty - a minimally invasive procedure for osteoporotic patients affected by spinal fractures Medtronic
25 Apr 13 Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013 CADENCE PHARMACEUTICALS INC.,
Published by
PR Newswire
25 Apr 13 HemoShear to Present Cardiovascular Drug Discovery Insights at Leading Scientific Conference HEMOSHEAR LLC,
Published by
PR Newswire
25 Apr 13 House Bill Preserves Medicare Patient Access to Doctor-Prescribed Equipment Says AAHomecare American Association for Homecare,
Published by
PR Newswire
25 Apr 13 Digital is Top-of-Mind Channel for Physicians in Growth Markets Manhattan Research
25 Apr 13 ViroPharma To Release 2013 First Quarter Financial Results On May 1, 2013 VIROPHARMA INC.,
Published by
PR Newswire
25 Apr 13 TransMedics® Announces Interim Results From The International INSPIRE Pivotal Trial Using The OCS™ Lung System TRANSMEDICS INC.,
Published by
PR Newswire
25 Apr 13 FUJIFILM DIOSYNTH BIOTECHNOLOGIES COMMISSIONS NEW CELL BANKING FACILITY AT BILLINGHAM, UK SITE Fujifilm Diosynth Biotechnologies
24 Apr 13 Lilly Again Named One of DiversityInc's Top 50 Companies for Diversity Lilly,
Published by
PharmiWeb.com
24 Apr 13 Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research Baxter
24 Apr 13 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck
24 Apr 13 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck
Advertising